Fukushima N, Nakamura M, Matsui M, Ikematsu H, Koike K, Ishibashi H, Hayashida K, Niho Y
First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Int Immunol. 1995 Jul;7(7):1047-55. doi: 10.1093/intimm/7.7.1047.
We established one Epstein-Barr virus-transformed B cell hybrid clone producing human mAb of the IgG class to the 2-oxoglutarate dehydrogenase complex (OGDC) for the first time from the peripheral B lymphocytes of a patient with primary biliary cirrhosis (PBC). This mAb, designated mAbM37GO37, specifically bound to OGDC and its dissociation constant with OGDC was calculated to be 3.70 x 10(-10) mol/l. mAbM37GO37 stained murine stomach/kidney cryostat sections in a typical immunofluorescence pattern of antimitochondrial antibody (AMA). Western blotting analysis revealed that mAbM37GO37 reacted with an E2 component of OGDC but not with other components of OGDC nor pyruvate dehydrogenase complex (PDC). Furthermore, mAbM37GO37 completely inhibited the enzymatic activity of OGDC. In order to determine the structure and genetic origin of anti-OGDC autoantibody, we cloned and sequenced the Ig heavy and light chain variable regions of mAbM37GO37. This mAb used the VHIII family member, V3-7, and the V kappa IV family member. The amino acid difference between the expressed V genes of this mAb and respective putative germline genes was concentrated within the complementarity determining regions (CDR) rather than the framework regions (FR). The R:S mutation ratio was high in the CDR and low in the FR. These features suggested that the immune response to OGDC is similar to that to exogenous antigen, and that the heavy and light chain variable regions of the anti-OGDC antibody undergo somatic hypermutation through antigen-driven clonal selection. This human mAb to OGDC, which was established for the first time from a patient with PBC and characterized at the molecular level, would be a valuable tool to study the B cell autoepitopes of OGDC, to clone as yet undetermined full length cDNA encoding OGDC and to dissect the autoimmune response to mitochondrial antigens in PBC.
我们首次从原发性胆汁性肝硬化(PBC)患者的外周B淋巴细胞中建立了一个爱泼斯坦-巴尔病毒转化的B细胞杂交克隆,该克隆产生针对2-氧代戊二酸脱氢酶复合物(OGDC)的IgG类人单克隆抗体。这种单克隆抗体命名为mAbM37GO37,它能特异性结合OGDC,其与OGDC的解离常数经计算为3.70×10⁻¹⁰mol/L。mAbM37GO37以抗线粒体抗体(AMA)典型的免疫荧光模式对小鼠胃/肾冰冻切片进行染色。蛋白质印迹分析表明,mAbM37GO37与OGDC的E2成分发生反应,但不与OGDC的其他成分或丙酮酸脱氢酶复合物(PDC)发生反应。此外,mAbM37GO37完全抑制了OGDC的酶活性。为了确定抗OGDC自身抗体的结构和遗传起源,我们克隆并测序了mAbM37GO37的Ig重链和轻链可变区。该单克隆抗体使用VHIII家族成员V3-7和VκIV家族成员。该单克隆抗体表达的V基因与各自推定的胚系基因之间的氨基酸差异集中在互补决定区(CDR)而非框架区(FR)。CDR中的R:S突变率高,而FR中的突变率低。这些特征表明,对OGDC的免疫反应与对外源抗原的免疫反应相似,并且抗OGDC抗体的重链和轻链可变区通过抗原驱动的克隆选择发生体细胞超突变。这种首次从PBC患者中建立并在分子水平上进行表征的针对OGDC的人单克隆抗体,将成为研究OGDC的B细胞自身表位、克隆尚未确定的编码OGDC的全长cDNA以及剖析PBC中线粒体抗原自身免疫反应的有价值工具。